UNSPSC 41131723: Leukocyte alkaline phosphatase test

In this classification a leukocyte alkaline phosphatase test is a device used to identify the enzyme leukocyte alkaline phosphatase in neutrophilic granulocytes (granular leukocytes stainable by neutral dyes). The cytochemical identification of alkaline phosphatase depends on the formation of blue granules in cells containing alkaline phosphatase. US FDA regulates Leukocyte alkaline phosphatase test under 21 CFR 864.7660 and under FDA product code GHD.

UNSPSC 41131723 Leukocyte alkaline phosphatase test (Commodity) does not reflect the work actually being solicited under this code in recent state and local procurement. The code nominally covers a specific hematologic laboratory test, but the recent opportunities tagged to it span drug testing services, employment screening, breath alcohol equipment, drug standards for forensic analysis, and medical director services—none of which involve leukocyte alkaline phosphatase testing. The mismatch is pervasive: Collin County's offender drug screening RFP requests immunoassay and LC/MS/MS or GC/MS confirmation for five- and six-panel screens; Benton County seeks urinalysis testing with confirmatory panels for amphetamines, barbiturates, benzodiazepines, opiates, cocaine, and fentanyl; City Colleges of Chicago is procuring employment screening and non-NIDA drug panels; and Pinellas County is buying certified reference materials (drug standards) for forensic toxicology. The Nevada Department of Public Safety solicitations request Intoxilyzer 9000 breath alcohol testing devices, and the State of Oregon is procuring clozapine assay kits for psychiatric patient monitoring. The issuing bodies include county criminal justice and health departments, city colleges, state public safety and health agencies, and county human resources offices across Florida, Oregon, Nevada, Texas, Illinois, and Washington jurisdictions.

The code shows no recent activity aligned with its stated scope. The posted opportunities—ranging from offender drug testing for Collin County (RFP 2026-327, due July 23, 2026, estimated value $600,000) through employment physicals for Clay County (IFB 2526054, due February 26, 2026) and City Colleges of Chicago employment screening (RFP MWJ2603, due March 30, 2026, with 25% MBE and 7% WBE set-asides)—represent forensic drug analysis, occupational health screening, substance-abuse monitoring, and breath alcohol enforcement rather than laboratory hematology. Until the taxonomy is corrected or opportunities are properly recoded, this Commodity code does not present a usable procurement signal for business development targeting state and local buyers.